FDA — authorised 23 December 1999
- Application: NDA021156
- Marketing authorisation holder: GD SEARLE LLC
- Local brand name: CELEBREX
- Indication: CAPSULE — ORAL
- Status: approved
FDA authorised Celecoxib(drug) on 23 December 1999
Yes. FDA authorised it on 23 December 1999.
GD SEARLE LLC holds the US marketing authorisation.